Back to News
Market Impact: 0.2
Indivior Pharmaceuticals, Inc. Declares Special Cash Dividend
Source: GlobeNewswire
M&A & RestructuringCapital Returns (Dividends / Buybacks)
The article states that payment of a special dividend is contingent on the closing of a pending merger transaction. No dividend amount, merger value, timeline, parties, or closing conditions were disclosed, limiting assessment of the financial impact.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.10
More News
- California AG Says Paramount-WBD Merger Would Hurt the State
- California AG Bonta on Paramount-Warner Bros., Meta and AI
- Jana Partners pushes Cooper to replace CEO, weigh asset sales- WSJ
- Lucid et Bolt s'associent pour développer et déployer à grande échelle des solutions de mobilité autonome en Europe
- Halozyme prices $1.3 billion convertible notes offering
- Paramount is getting an assist from a key California pol as it defends its Warner merger against AG Rob Bonta